X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Clinical Trials News - 27/Aug 23:08

Lilly Releases Zepbound (tirzepatide) Single-Dose Vials, Expanding Supply and Access for Adults Living with Obesity

INDIANAPOLIS, Aug. 27, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced Zepbound® (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly...

Articles similaires

Sorry! Image not available at this time

In a First-of-its-kind Fixed Dose Study, Once Weekly Insulin Efsitora Alfa Leads to A1C Reduction Similar to Daily Insulin

drugs.com - 05/Sep 06:09

INDIANAPOLIS, Sept. 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the QWINT-1 and QWINT-3...

Sorry! Image not available at this time

In a First-of-its-kind Fixed Dose Study, Once Weekly Insulin Efsitora Alfa Leads to A1C Reduction Similar to Daily Insulin

drugs.com - 05/Sep 06:09

INDIANAPOLIS, Sept. 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the QWINT-1 and QWINT-3...

Sorry! Image not available at this time

FDA Approves Ebglyss (lebrikizumab-lbkz) for the Treatment of Atopic Dermatitis

drugs.com - 13/Sep 00:09

INDIANAPOLIS, Sept. 13, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved...

Sorry! Image not available at this time

Once-weekly dose of insulin efsitora alfa delivers A1C reduction consistent with the most advanced daily insulin in people with type 2 diabetes

drugs.com - 10/Sep 15:09

INDIANAPOLIS, Sept. 10, 2024. Eli Lilly and Company today announced detailed results from the QWINT-2 phase 3 trial evaluating once-weekly insulin...

Sorry! Image not available at this time

Once-weekly dose of insulin efsitora alfa delivers A1C reduction consistent with the most advanced daily insulin in people with type 2 diabetes

drugs.com - 10/Sep 15:09

INDIANAPOLIS, Sept. 10, 2024. Eli Lilly and Company today announced detailed results from the QWINT-2 phase 3 trial evaluating once-weekly insulin...

Sorry! Image not available at this time

Bull of the Day: Eli Lilly (LLY)

zacks.com - 12/Sep 08:30

Eli Lilly stock boasts both defensive and growth characteristics

Sorry! Image not available at this time

Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy?

zacks.com - 04/Sep 16:00

Does Eli Lilly (LLY) have what it takes to be a top stock pick for momentum investors? Let's find out.

Sorry! Image not available at this time

Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy?

zacks.com - 04/Sep 16:00

Does Eli Lilly (LLY) have what it takes to be a top stock pick for momentum investors? Let's find out.

Sorry! Image not available at this time

Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know

zacks.com - 06/Sep 13:00

Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.

Sorry! Image not available at this time

Is Most-Watched Stock Eli Lilly and Company (LLY) Worth Betting on Now?

zacks.com - 17/Sep 13:00

Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Les derniers communiqués